it is pretty obvious that most shareholders grasp the strategy that has been promoted all along for how and when and what to vote to get the best price
therefore I think Pfizer needs to act rather sooner with the ch’ching or they run out of time
GLTA
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-40
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #